ClinicalTrials.gov
ClinicalTrials.gov Menu

Prospective Study of Rapamycin for the Treatment of SLE (Rapamune)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00779194
Recruitment Status : Completed
First Posted : October 24, 2008
Last Update Posted : October 14, 2016
Sponsor:
Collaborator:
Pfizer
Information provided by (Responsible Party):
Andras Perl, MD, Ph.D, State University of New York - Upstate Medical University